Research Professor Oliver Bandmann (Courtesy Photo)
Research Professor Oliver Bandmann (Courtesy Photo)

(Daily Mirror) – Parkinson’s Disease victims could be helped by a drug used for liver disease.

Scientists found ursodeoxycholic acid increased energy levels in the cells of Parkinson’s sufferers.

They found it can slow the development of the condition, which affects 127,000 people in the UK.

As UDCA is already approved for treating liver disease, scientists hope it could be approved for Parkinson’s patients very quickly if more clinical trials prove its worth.

READ MORE

Leave a comment

Your email address will not be published. Required fields are marked *

Yes, I would like to receive emails from Washington Informer Newspaper. Sign me up!


By submitting this form, you are consenting to receive marketing emails from: Washington Informer Newspaper, 3117 Martin Luther King Jr. Ave SE, Washington, DC, 20032, https://www.washingtoninformer.com. You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact